| Controls (n = 20) | MI Patients(n = 48) | P-value†| P-value‡ | |
---|---|---|---|---|---|
 | pEF (12) | rEF (36) |  |  | |
Age (years) | 52.3 ± 11.2 | 57.1 ± 10 | 57.3 ± 12 | 0.10 | 0.93 |
Gender (Male, n) | 12 | 9 | 30 | 0.07 | 0.53 |
Body surface area | 1.8 ± 0.2 | 1.9 ± 0.3 | 1.98 ± 0.4 | 0.69 | 0.68 |
Acute MI (n) | – | 8 | 27 | – | 0.58 |
Heart rate (bpm) | 65 ± 12 | 58 ± 10 | 66 ± 14 | 0.75 | 0.045 |
Standard CMR clinical parameters | |||||
 LVMi (g/m2) | 51.0 ± 10.2 | 57.7 ± 16.6 | 62 ± 19 | 0.02 | 0.46 |
 LVEDVi (ml/m2) | 81.6 ± 15.6 | 80 ± 10 | 103 ± 30 | 0.02 | 0.01 |
 LVESVi (ml/m2) | 30.0 ± 7.4 | 32 ± 6 | 64 ± 30 | < 0.01 | < 0.01 |
 SVi (ml/m2) | 51.6 ± 10.7 | 48 ± 5 | 38 ± 9 | < 0.01 | < 0.01 |
 EF (%) | 63.1 ± 5.6 | 60 ± 3 | 39 ± 11 | < 0.01 | < 0.01 |
 IS (% of LV) | – | 12.3 ± 9 | 25 ± 12 | – | < 0.01 |
 CI (L/min/m2) | 3.3 ± 0.9 | 2.7 ± 0.47 | 2.5 ± 4.6 | 0.03 | 0.11 |
LV KEiEDV parameters | |||||
 LV (μJ/ml) | 8.5 ± 2.7 | 7 ± 4 | 6.3 ± 3 | 0.02a | 0.11 |
 Minimal (μJ/ml) | 0.95 ± 0.63 | 0.5 ± 0.3 | 0.8 ± 0.6 | 0.02a | 0.02 |
 Systolic (μJ/ml) | 9.2 ± 3.8 | 8.4 ± 6 | 6.4 ± 2 | < 0.01a | < 0.01 |
 Diastolic (μJ/ml) | 7.5 ± 4.2 | 7 ± 3 | 6.3 ± 3.5 | 0.29 | 0.92 |
 E-wave (μJ/ml) | 22.0 ± 10.2 | 19 ± 8 | 15 ± 9 | 0.02a | 0.30 |
 A-wave (μJ/ml) | 12.5 ± 5.6 | 14 ± 9 | 10.6 ± 7 | 0.22 | < 0.01 |
 In-plane LV (%) | 36.5 ± 7.2 | 31 ± 4.4 | 38 ± 8 | 0.84 | < 0.01 |
 TD (msecs) | 11 ± 31 | 33.6 ± 12 | 34.2 ± 52 | < 0.01a | 0.21 |